Thank you all for the input here. While I think we all
Thank you all for the input here. While I think we all have concerns about financing and the potential risks involved to take leronlimab alone, the conversations here remain constructive and helpful. Like CI, I appreciate contrary points of view from those of my own if they are based on substance and presented in a decent manner.
Personally I am glad management and the BOD is addressing this now and not later when they would be forced to and it would be much more difficult to implement a successful launch. Is this simply a negotiation tactic? Possibly, but IMO there is also some serious consideration that this may actually play out and the BOD has drawn a line in the sand that will determine which path is taken.
I do think they will have a deal for the PCa test relatively soon (within 3 months). How much upfront payment will this bring in, I am not sure? Say the mid-point BD mentions ($50M-150M) to establish a team is $100M and they need ~$50M to keep the trials going and lights on for 12 months, that is $150M until revenue. I don't see the PCa test bringing in that amount of up-front cash....so as others mentioned dilutive financing will likely be needed. Maybe they will do some small raises until the PCa deal is closed and dilute later with a higher SP as lorbas noted? I would be okay with a little further dilution at a higher share price also. Also, much of the $100M marketing and sales expense wouldn't occur until sales begin as Zuess mentioned much of this cost is commission, so maybe this $100M figure is high? I would assume there would be a base salary, training and travel costs needed 3-6 months pre-launch (at minimum).
While I hope they are able to come to terms for an HIV deal as it removes most of the uncertainty and risk that remains for CYDY, I also don't think it is impossible to successfully bring HIV to market alone either.....and the risk may be worth the reward down the road (but it may be a bumpy ride).
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Educational opportunities shouldn't feel like a game of chance, yet that's often the reality for many families out there. The K-12 Scholarship Foundation is making a play to level the educational playing field. With scholarship applications now open in 32 states, and pre-registration available in 18 more—including the District of Columbia—this nonprofit aims to extend...
Continue Reading
Understanding Anchorage's Real Estate Climate In the bustling world of Anchorage real estate, it's not what you hear nationally that counts—it's about reading the nuances of your own backyard. That’s the principal mantra disseminated by Real Estate Expert Gary Cox, affectionately known as the 'King', in his latest discourse with HelloNation. A pertinent perspective...
Continue Reading
A One-Touch Solution in the DUI Landscape Kicking off today's market chatter, Intoxalock—the heavyweight in ignition interlock devices—is rolling out its sparkly new one-touch breathalyzer in the states of Pennsylvania and New Jersey. Now, these developments might not sound like Wall Street headliners at first glance, but don't blink; they've got teeth for those of us...
Continue Reading
Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...
Continue Reading
Beyond BMI: Rethinking Obesity Diagnosis If you ever thought body mass index (BMI) was the ultimate measure of obesity, think again. A groundbreaking study, featuring over 844,000 adults and spanning four countries, pokes holes in that assumption and delivers a wake-up call on how we diagnose obesity and assess health risks. Led by King's College London, this research...
Continue Reading
Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....
Continue Reading
Spotlight on Health and Innovation at HNCEXPO In the bustling city of Shenzhen, where skyscrapers meet the sea, HNCEXPO 2026 wrapped up a colorful spectacle, leaving a vibrant impression on the health and nutrition industry. This isn't just any trade show—it's where global innovators gather to showcase the latest in nutraceuticals, dietary supplements, and smart senior...
Continue Reading
Welcome to the Future of Home Energy If you thought home energy systems couldn't get any slicker, Huawei's got news for you. They just dropped the LUTERRA S2, a swanky, all-in-one residential energy system that's about to put your old setup to shame. This ain’t your granddad's inverter. We're talking hybrid functionality with storage and AI-driven energy management...
Continue Reading
Charting VTech's Financial Waters Well, here we are – another chapter in the saga of VTech, the electronic learning product titan. This time, they've danced a jig of higher revenues, a sweet 5.6% jump to $1,046.9 million for the six months leading to September 2026. But hang on, the party's not all balloons and confetti. Profit margins? They're bobbing like a ship in a...
Continue Reading
The Big Poker Showdown Now, this is more like it. ACR Poker's $20 million guaranteed Online Super Series (OSS) is back in town, turning the virtual felt into a battlefield. We're talking a lineup that's more stacked than the chips at a high-stakes table. This series is running from November 8–24, and it's not just about the cash. They've thrown in over $77,000 in...
Continue Reading
Top 5 Most Recently Viewed Articles
CYIOS Corp. Welcomes John O’Shea as New CEO CYIOS Corp. (OTC: CYIO), a dynamic holding company focused on innovative and high-growth businesses in the medical and technology sectors, is excited to announce the appointment of John O'Shea as its Chief Executive Officer and Chairman of the Board. This decision marks a pivotal moment for the company as it aims to expand and...
Continue Reading
Danske Bank A/S: Insights into Managerial Transactions In the realm of corporate finance, understanding transactions handled by individuals in key managerial roles is vital for transparency and investor confidence. Danske Bank A/S, a prominent financial institution, has recently notified relevant stakeholders regarding significant transactions made by those required to...
Continue Reading
Orgenesis Begins Trading on OTCQX Orgenesis Inc, a prominent player in the biotech sector dedicated to enhancing cell and gene therapies, has recently made a significant shift by commencing trading on the OTCQX Best Market under the ticker symbol "ORGS". This transition comes after the company faced delisting from the Nasdaq Stock Market due to not meeting the necessary...
Continue Reading
Overview of the Class Action Lawsuit The law firm Glancy Prongay & Murray LLP has launched a class action lawsuit concerning AMMO, Inc. (NASDAQ: POWW). This legal action is being pursued on behalf of investors who acquired AMMO securities during a specified period. The lawsuit was filed in the United States District Court for the District of Arizona and highlights...
Continue Reading
Saratoga Investment's Quarterly Earnings Anticipation Saratoga Investment (NYSE: SAR) is preparing to announce its upcoming quarterly earnings, which is generating a buzz among investors. With projections being an essential aspect of stock evaluations, this report is particularly important for those invested in the company. Analysts are forecasting that Saratoga...
Continue Reading
